- PR Newswire•yesterday
SOUTH PLAINFIELD, N.J., Feb. 21, 2017 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) today announced that on February 20, 2017 it approved non-statutory stock options to purchase an aggregate of 55,900 shares of its common stock to 14 new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of our new hires' employment compensation. The inducement grants were approved by PTC's Compensation Committee on February 20, 2017 and are being made as an inducement material to each employee's acceptance of employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4).
- Benzinga•7 days ago
PTC Therapeutics, Inc. (NASDAQ: PTCT ) shares popped Thursday morning, following a note from Credit Suisse that said the stock could trade up by more than 500 percent.. The predicted activity will depend ...
- Zacks•10 days ago
Investors in PTC Therapeutics, Inc. (PTCT) need to pay close attention to the stock based on moves in the options market lately.
PTCT : Summary for PTC Therapeutics, Inc. - Yahoo Finance
PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||10.50 x 500|
|Ask||14.40 x 1000|
|Day's Range||12.87 - 13.61|
|52 Week Range||4.03 - 16.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.72|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|